BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 23660489)

  • 1. May you never forget what is worth remembering: the relation between recall of medical information and medication adherence in patients with inflammatory bowel disease.
    Linn AJ; van Dijk L; Smit EG; Jansen J; van Weert JC
    J Crohns Colitis; 2013 Dec; 7(11):e543-50. PubMed ID: 23660489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying youth nonadherence in clinical settings: data-based recommendations for children and adolescents with inflammatory bowel disease.
    Greenley RN; Kunz JH; Biank V; Martinez A; Miranda A; Noe J; Telega G; Tipnis NA; Werlin S; Stephens MC
    Inflamm Bowel Dis; 2012 Jul; 18(7):1254-9. PubMed ID: 22689633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in inflammatory bowel disease.
    Mountifield R; Andrews JM; Mikocka-Walus A; Bampton P
    J Crohns Colitis; 2014 Dec; 8(12):1723-9. PubMed ID: 25263934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to medical treatment in inflammatory bowel disease patients.
    Zelante A; De Giorgi A; Borgoni R; Trevisani L; Gallerani M
    Minerva Gastroenterol Dietol; 2014 Dec; 60(4):269-74. PubMed ID: 25384805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions and Attitudes Towards Medication Adherence during Pregnancy in Inflammatory Bowel Disease.
    Gallinger ZR; Rumman A; Nguyen GC
    J Crohns Colitis; 2016 Aug; 10(8):892-7. PubMed ID: 26896087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing Self-reported Medication Adherence in Inflammatory Bowel Disease: A Comparison of Tools.
    Severs M; Zuithoff PN; Mangen MJ; van der Valk ME; Siersema PD; Fidder HH; Oldenburg B
    Inflamm Bowel Dis; 2016 Sep; 22(9):2158-64. PubMed ID: 27482979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease.
    Kane S; Becker B; Harmsen WS; Kurian A; Morisky DE; Zinsmeister AR
    Am J Gastroenterol; 2012 Feb; 107(2):154-60. PubMed ID: 22306937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' beliefs and attitudes about their treatment for inflammatory bowel disease in Korea.
    Kim SB; Kim KO; Jang BI; Kim ES; Cho KB; Park KS; Chung MK; Jeon SW;
    J Gastroenterol Hepatol; 2016 Mar; 31(3):575-80. PubMed ID: 26313162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.
    Gilissen LP; Wong DR; Engels LG; Bierau J; Bakker JA; Paulussen AD; Romberg-Camps MJ; Stronkhorst A; Bus P; Bos LP; Hooymans PM; Stockbrügger RW; Neef C; Masclee AA
    J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Accuracy of Adherence Self-report Scales in Patients on Thiopurines for Inflammatory Bowel Disease: A Comparison With Drug Metabolite Levels and Medication Possession Ratios.
    Selinger CP; Ochieng AO; George V; Leong RW
    Inflamm Bowel Dis; 2019 Apr; 25(5):919-924. PubMed ID: 30265299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy and IBD treatment: this challenging interplay from a patients' perspective.
    Mountifield RE; Prosser R; Bampton P; Muller K; Andrews JM
    J Crohns Colitis; 2010 Jun; 4(2):176-82. PubMed ID: 21122502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era.
    Campos S; Portela F; Sousa P; Sofia C
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1313-9. PubMed ID: 27501126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index.
    de Castro ML; Sanromán L; Martín A; Figueira M; Martínez N; Hernández V; Del Campo V; Pineda JR; Martínez-Cadilla J; Pereira S; Rodríguez Prada JI
    Rev Esp Enferm Dig; 2017 Aug; 109(8):542-551. PubMed ID: 28679280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained improvement in health-related quality of life measures in patients with inflammatory bowel disease receiving prolonged anti-tumor necrosis factor therapy.
    Sherman M; Tsynman DN; Kim A; Arora J; Pietras T; Messing S; St Hilaire L; Yoon S; Decross A; Shah A; Saubermann L
    J Dig Dis; 2014 Apr; 15(4):174-9. PubMed ID: 24373601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory Bowel Disease in the COVID-19 Pandemic: the Patients' Perspective.
    Grunert PC; Reuken PA; Stallhofer J; Teich N; Stallmach A
    J Crohns Colitis; 2020 Dec; 14(12):1702-1708. PubMed ID: 32564068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of medication adherence in inflammatory bowel disease.
    Ediger JP; Walker JR; Graff L; Lix L; Clara I; Rawsthorne P; Rogala L; Miller N; McPhail C; Deering K; Bernstein CN
    Am J Gastroenterol; 2007 Jul; 102(7):1417-26. PubMed ID: 17437505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].
    Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL
    Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of Patients' Knowledge of Their Prescribed Medication in Improving Treatment Adherence in Inflammatory Bowel Disease.
    Tae CH; Jung SA; Moon HS; Seo JA; Song HK; Moon CM; Kim SE; Shim KN; Jung HK
    J Clin Gastroenterol; 2016 Feb; 50(2):157-62. PubMed ID: 26501880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-medication with steroids in inflammatory bowel disease.
    Filipe V; Allen PB; Peyrin-Biroulet L
    Dig Liver Dis; 2016 Jan; 48(1):23-6. PubMed ID: 26611334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
    Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
    J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.